Cellular Biology |
From the Second Department of Internal Medicine (S.A., H.I., Y.O., T.N., S.A., F.M., M.H.), Department of Biochemical Genetics, Medical Research Institute (M.T.-A.), and Department of Developmental Biology, Graduate School of Dentistry (M.I.), Tokyo Medical and Dental University, Tokyo, Japan.
Correspondence to Michiaki Hiroe, MD, Second Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
AbstractCardiomyocytes
are terminally differentiated cells characterized as withdrawal
cell-cycle machinery, but nonetheless they are known to express
cell-cycle regulators. Because many proteins related to the cell cycle
induce apoptosis in proliferating cells, we examined the involvement of
these proteins in the apoptosis pathway in cardiomyocytes. Primary rat
cardiomyocytes were exposed to a severe hypoxic condition to induce
apoptosis. The apoptosis rate of cardiomyocytes increased to
40%
under 24 hours of hypoxia as evaluated by the TUNEL method. The cyclin
A protein level assessed by immunoblot analysis accumulated in a
time-dependent manner in cardiomyocytes, but there was no increase in
nonmyocytes. Hypoxia increased the activity of cyclin Aassociated
kinase but not the activity of cyclin Eassociated kinase, and the
apoptosis was inhibited by infection of dominant-negative cdk2
adenovirus, suggesting that cyclin A and its associated kinase play
significant roles in the apoptosis of cardiomyocytes. To investigate
the cyclin Amediated apoptosis, we infected cultured cells with
cyclin A adenovirus. Apoptosis was induced in 63±12% of the infected
cardiomyocytes in contrast to only 12±3% of the LacZ-infected control
cells. In addition, the cells in the hypoxic condition showed an
increase in caspase-3 activity and a subsequent decrease in
p21cip1/waf1 protein, which is partly
cleaved by caspase-3. These findings confirm that cyclin Aassociated
kinase mediates hypoxia-induced apoptosis in cardiomyocytes, and they
also suggest that additional elements of the cell-cycledependent
machinery participate in this
mechanism.
Key Words: apoptosis hypoxia cardiomyocytes cell cycle
This article has been cited by other articles:
![]() |
F. Yu, J. Megyesi, and P. M. Price Cytoplasmic initiation of cisplatin cytotoxicity Am J Physiol Renal Physiol, July 1, 2008; 295(1): F44 - F52. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yamasaki, D. Zhang, C. Bartholomeusz, T. Sudo, G. N. Hortobagyi, K. Kurisu, and N. T. Ueno Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity Mol. Cancer Ther., August 1, 2007; 6(8): 2168 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhan, J. B. Easton, S. Huang, A. Mishra, L. Xiao, E. R. Lacy, R. W. Kriwacki, and P. J. Houghton Negative Regulation of ASK1 by p21Cip1 Involves a Small Domain That Includes Serine 98 That Is Phosphorylated by ASK1 In Vivo Mol. Cell. Biol., May 1, 2007; 27(9): 3530 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Price, F. Yu, P. Kaldis, E. Aleem, G. Nowak, R. L. Safirstein, and J. Megyesi Dependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2 J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2434 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gui and X.-L. Zheng 2-Methoxyestradiol Induces Cell Cycle Arrest and Mitotic Cell Apoptosis in Human Vascular Smooth Muscle Cells Hypertension, February 1, 2006; 47(2): 271 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price Identification of the functional domain of p21WAF1/CIP1 that protects cells from cisplatin cytotoxicity Am J Physiol Renal Physiol, September 1, 2005; 289(3): F514 - F520. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takahashi, F. Yamasaki, T. Sudo, H. Itamochi, S. Adachi, M. Tamamori-Adachi, and N. T. Ueno Cyclin A-associated kinase activity is needed for paclitaxel sensitivity Mol. Cancer Ther., July 1, 2005; 4(7): 1039 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Han, J.-K. Chae, M.-J. Lee, K.-R. You, B.-H. Lee, and D.-G. Kim Involvement of GADD153 and Cardiac Ankyrin Repeat Protein in Hypoxia-induced Apoptosis of H9c2 Cells J. Biol. Chem., June 17, 2005; 280(24): 23122 - 23129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ebelt, N. Hufnagel, P. Neuhaus, H. Neuhaus, P. Gajawada, A. Simm, U. Muller-Werdan, K. Werdan, and T. Braun Divergent Siblings: E2F2 and E2F4 but not E2F1 and E2F3 Induce DNA Synthesis in Cardiomyocytes Without Activation of Apoptosis Circ. Res., March 18, 2005; 96(5): 509 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Dutta, R. Z. Sabirov, H. Uramoto, and Y. Okada Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions J. Physiol., September 15, 2004; 559(3): 799 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pignatti and C. Stefanelli Ischemia/reperfusion-induced apoptosis: connecting nitric oxide and cell cycle regulators Cardiovasc Res, August 1, 2003; 59(2): 268 - 270. [Full Text] [PDF] |
||||
![]() |
Y. Maejima, S. Adachi, H. Ito, K. Nobori, M. Tamamori-Adachi, and M. Isobe Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity Cardiovasc Res, August 1, 2003; 59(2): 308 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimizu, M. Tamamori-Adachi, H. Arai, N. Tabuchi, H. Tanaka, and M. Sunamori Lipopolysaccharide pretreatment attenuates myocardial infarct size: A possible mechanism involving heat shock protein 70-inhibitory {kappa}B{alpha} complex and attenuation of nuclear factor {kappa}B J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 933 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hauck, G. Hansmann, R. Dietz, and R. von Harsdorf Inhibition of Hypoxia-Induced Apoptosis by Modulation of Retinoblastoma Protein-Dependent Signaling in Cardiomyocytes Circ. Res., November 1, 2002; 91(9): 782 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gartel and A. L. Tyner The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis Mol. Cancer Ther., June 1, 2002; 1(8): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Hardt and J. Sadoshima Glycogen Synthase Kinase-3{beta}: A Novel Regulator of Cardiac Hypertrophy and Development Circ. Res., May 31, 2002; 90(10): 1055 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi, A. J. Obaya, Z. Han, N. Ramos-Desimone, J. H. Wyche, and J. M. Sedivy c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle Mol. Cell. Biol., August 1, 2001; 21(15): 4929 - 4937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Schneider and W. R. MacLellan Cyclin-Dependent Kinase-2 in the Birth and Death of Cardiac Muscle Cells Circ. Res., March 2, 2001; 88(4): 367 - 369. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |